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Degenerative diseaseTheperoxisome is functionally integrated into an exquisitely complex network of communicating endomembranes
which is only beginning to be appreciated. Despite great advances in identifying essential components and
characterizing molecular mechanisms associated with the organelle's biogenesis and function, there is a large gap
in our understanding of how peroxisomes are incorporated into metabolic pathways and subcellular
communication networks, how they contribute to cellular aging, and where their inﬂuence is manifested on the
initiation and progression of degenerative disease. In this review, we summarize recent evidence pointing to the
organelle as an important regulator of cellular redox balance with potentially far-reaching effects on cell aging and
the genesis of human disease. The roles of the organelle in lipid homeostasis, anaplerotic reactions, and other
criticalmetabolic and biochemical processes are addressed elsewhere in this volume. This article is part of a Special
Issue entitled: Metabolic Functions and Biogenesis of Peroxisomes in Health and Disease.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
The role of cellular senescence in organismal aging bursts into our
collective consciousness this past fall with the publication of a paper
by Dr. Jan Van Deursen and colleagues at the Mayo Clinic College of
Medicine in Rochester, Minnesota. In their landmark work, the team
showed that eliminating senescent cells in a mouse model delayed
appearance of age-related disorders [1]. Importantly, the strategy was
effective both when clearance was started from birth, as well as when
initiated later in life. However, in the latter case, already existing
pathologies were not reversed, rather their progression was thwarted.
In many ways, this research serves as the ultimate conﬁrmation of
whatmany had long speculated— that senescent cells amass in tissues
and organs of aging animals and contribute to their physiological
decline. What a long way the ﬁeld had come from days when cellular
senescence was considered an in vitro phenomenon, not applicable to
thewhole animal. In fact, it is only some six years since Dr. John Sedivy
and colleagues at Brown University in Providence, Rhode Island,
conﬁrmed the existence of senescent cells in the tissue of aging
primates [2].
A considerable literature exists concerning exactly what cellular
senescence is (for example, see [3] for a detailed and current review);
therefore, the phenomenawill only be brieﬂy described here. Senescent
cells have lost their ability to replicate, yet remain metabolically active.
The cells are enlarged and express so-called senescence markers,lic Functions and Biogenesis of
+1 313 577 6739.
lecky).
l rights reserved.including an alkaline β-galactosidase activity, heterochromatin and/or
DNA damage foci, and the cyclin-dependent kinase inhibitor/tumor
suppressor, p16Ink4a. (Eradication of (senescent) cells expressing the
latter biomarker was the mechanism employed by the Van Deursen
group to largely eliminate diseases of aging inmice.) Senescent cells are
resistant to apoptosis and exhibit a distinct “secretory phenotype”
(reviewed in [4]). They secrete a number of bioactive molecules,
including cytokines, growth factors, inﬂammatory mediators, and
various proteases. Secretion of these molecules undoubtedly alters the
cell and tissue microenvironments with potentially important implica-
tions on aging and disease phenomena. Indeed, there is an emergent
consensus view, articulated by Dr. Manuel Collado and co-authors [5]
among others, that tissue aging results from the combined effects of an
accumulation of senescent cells and accompanying secretions, and the
loss of stem cell renewal capacities.1
Triggers of replicative senescence include telomere shortening,
accumulation of reactive oxygen species and associated damage to
cellularmacromolecules, DNA alterations and accompanying responses,
a loss of cell cycle checkpoint regulation, and the effects of environ-
mental or intrinsic stressors including oncogenes. Importantly, these
activators do not necessarily act alone; rather, they may cooperate to
elicit the growth stasis and accompanying cellular changes associated
with the senescent phenotype.
Is there a reason senescence happens? A widely supported view is
that senescence exists to suppress tumor formation; cells that are
incapable of dividing cannot contribute to cancer — at least not
directly. But as Dr. Judith Campisi [6] and others argue, senescence1 The extent to which stem cells actually senesce is not clear; regardless, their
diminished function certainly compromises tissue integrity.
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cancer, but permissive of an environment later in life which potentiates
transformation. Consider the senescent cell's tissue milieu; rich in
growth-promoting secreted biomolecules, rich in oxidants, and rich in
functionally compromised stem cells. This is an environment ripe for
cancerous transformation. Thus, the thought is cancer is held in check
early, but may thrive later. Consistent with this notion is the fact that
cancer is a disease of aging— the older the individual, the more likely is
tumorigenesis.
2. Peroxisomes
2.1. Overview of biogenesis
To be able to position peroxisomes as players in cellular aging
processes, an overview of their assembly and function is warranted.
Peroxisome biogenesis is brought about by a series of proteins
termed peroxins (see [7,8] for recent analyses). The organelle's mem-
brane is derived by growth and division of pre-existing peroxisomes
[9], as well as by recruitment from certain endoplasmic reticulum
subdomains [10]. Peroxisomal enzymes, synthesized on cytoplasmic
ribosomes and containing speciﬁc targeting signals, are recognized
post-translationally and directed to the organelle's membrane. A
surface-associated docking complex then engages the to-be-imported
enzyme and its cognate receptor, and channels the complex to a still
rather enigmatic translocation machinery. Mechanisms exist to recycle
components of the import apparatus as well as to regulate luminal
enzyme levels, and organelle number.
2.2. Overview of biological functions
Peroxisomes are critical contributors to cell metabolism, tissue
and organ function, and organismal well-being. They house dozens of
enzymes involved in biosynthetic reactions (reviewed in [11,12]),
including those that produce ether phospholipids, as well as bile and
docosahexaenoic acids. Among the ether phospholipids produced
are plasmalogens, essential constituents of myelin, the nerve process
insulating material. Bile acids are well described participants in
dietary fat metabolism; docosahexaenoic acids are omega-3 fatty acids
essential for nervous system development and function. The latter
molecules also appear to be derivatized into important mediators
capable of inﬂammatory-suppression/modulation.
Peroxisomes also affect inﬂammation through their ability to
degrade eicosanoids, signaling molecules with a wide array of
biological targets and elicited effects. Peroxisomal enzymes degrade
a number of other substrates including particular long-chain, very-
long-chain, and branched-chain fatty acids. Defects in such process-
ing result in accumulation of these molecules and, in many cases,
disease and even death ensue. Metabolism of peroxisomal fatty acids
occurs through biochemical oxidations; molecular oxygen is the
electron acceptor and hydrogen peroxide is formed (see [13] for an
overview of peroxisomes as oxidative organelles). This hydrogen
peroxide and related downstream reactive oxygen species appear to
play important roles in cell signaling and communication networks,
in hormetic processes, as well as in initiating and progressing age-
related declines in cell function (reviewed in [14]).
2.3. Contribution to cellular reactive oxygen species levels
Peroxisomal hydrogen peroxide is subject to metabolism by
organellar catalase, members of the peroxiredoxin family, and gluta-
thione peroxidase (presumably in some combination with reduced
glutathione and a reductase). As catalase is the most abundant and
efﬁcient hydrogen peroxidemetabolizer, most discussions about peroxi-
somal antioxidant capacities focus on the heme-containing tetrameric
enzyme.3. Catalase
3.1. Overview of the antioxidant enzyme
There exist individuals whose catalase levels are reduced due to
instability of the protein or its mRNA; cells from these subjects display
an accelerated aging phenotype [15]. They amass hydrogen peroxide,
possess elevated levels of oxidized proteins and damaged DNA, contain
functionally compromised peroxisomes and exhibit a growth stasis.
Coupledwith their altered, largely swollen and amorphous phenotypes,
these cells could very well be described as senescent except that they
do not express the histochemical biomarker, senescent-associated
β-galactosidase [15]. Similar progeric effects are seen in cells where
catalase is deactivated with the irreversible inhibitor, 3-amino-1,2,
4-triazole [16]. Coupledwith powerful epidemiological evidence suggest-
ing that the absence of cellular catalase is directly correlated with
premature onset of age-related disease [17,18] — a strong case emerges
for a critical role of the enzyme in preventing oxidative stress in cells.
3.2. Catalase, lifespan, and rate of aging
Catalase received very high proﬁle attentionwhen studies published
by Dr. Samuel Schriner and co-authors [19,20] showed that transgenic
mice expressing catalase in mitochondria manifest a 20% increase in
median lifespan and a 10% extension of maximum lifespan. (Perox-
isomally targeted catalase showed a more muted effect, which may
stem from how the molecule was directed to the organelle — a point
considered further below.) Mitochondrial catalase delayed aging
phenomena in the heart and eyes, reduced hydrogen peroxide levels
in cells, and decreased mitochondrial DNA damage while maintaining
mitochondrial function. Fitting these results into a simple model is
somewhat problematic [21], however, it is probably safe to conclude, as
the authors do [19,20], that reduced cellular oxidative stress positively
impacts longevity. Another important conclusion drawn from their
studies was that mitochondria were now seen as both sources of
reactive oxygen species, and targets of their destructive power.
More recent studies with these mice conﬁrmed that age-associated
declines in mitochondrial integrity and function were slowed, but also
that (muscle) insulin sensitivity and lipid content were maintained at
more youthful levels [22]. Based on their important ﬁndings, the
authors speculated that mitochondrial reactive oxygen species damage
the organelle and potentiate insulin resistance in the animals— leading
ultimately to downstream pathologies including a type 2 diabetes
phenotype.
As important as all of this is, we should not lose sight of the fact
that normally, catalase is not found in the mitochondria — it is a
peroxisomal enzyme. Perhaps, in future work, mechanisms could be
developed to direct newly introduced/suitably expressed catalase, or
an appropriate mimetic, to mitochondria. However, we are a long
way off from this at present. What we are closer to, is understanding
that a redox-sensitive interplay exists between mitochondria and
peroxisomes — one that catalase may play a very important part of.
Moreover, unlike mitochondria, peroxisomes may very well be
druggable targets in a way mitochondria cannot. The reader is
directed to [23] for further analysis of this latter point. Additional
discussion of the peroxisome-mitochondria connection is included
below — after a brief description of an important study linking
catalase, caloric restriction, and longevity.
As a critical antioxidant and one of the most efﬁcient enzymes
ever described, catalase has had its share of attention from the aging
ﬁeld. Studies have documented that catalase levels decline with age
but are maintained or elevated in more long-lived species. One
particularly interesting recent study, headed by Dr. Shugo Watabe,
looked at the effects of caloric restriction in the freshwater animal,
the rotifer (Brachionus plicatilis) [24]. Rotifers live, on average, some
8.8 days. Calorically restricted animals live 13.5 — an approximately
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they reproduce by an asexual process in which daughters are
genetically identical to their mothers. The research team asked what
happened to offspring of ad libitum-fed animals, versus those
subjected to a restricted diet. Not unexpectedly, animals from fed
mothers displayed a typical (~9.5 day) lifespan, which could be
extended to 14.4 days by a calorie limited diet. Interestingly, offspring
from calorically restricted mothers lived 12.7 days when not nutri-
tionally limited, and 16.8 days when the diet was modiﬁed. A lifespan
enhancing trait was transmitted, presumably by an epigenetic
process, to otherwise genetically identical offspring.
Dr. Watabe and colleagues identiﬁed that activity— it was catalase
[24]. The antioxidant enzyme was expressed at higher levels in
offspring of calorically restricted mothers. Manganese superoxide
dismutase, a powerful mitochondrial antioxidant enzyme, showed no
such behavior. Does the increased catalase activity protect the
organism from oxidative stress and contribute to its longevity? The
overwhelming conclusion of this study was that it absolutely does.
Two ﬁnal points regarding this work are identiﬁed; ﬁrst, the research
is of interest not only from a rate of aging perspective, but it also
provides evidence of “transgenerational plasticity” with its accom-
panying “adaptive” potential [24]. Second, regarding catalase and
caloric restriction; this work conﬁrms and extends what has already
been shown in a number of model organisms. Speciﬁcally, levels of
the enzyme are increased in cells of animals whose caloric intake is
limited.3.3. Catalase supplementation and a peroxisome–mitochondria redox
interplay
Catalase is progressivelymislocalized (to the cytosol) as cells age and
approach replicative senescence [25,26]. Concomitantly, these cells
produce reactive oxygen species, manifest an ever more compromised
peroxisomal import apparatus, and proliferate the organelle in an
apparent attempt to compensate for functional shortfalls.2 As pointed
out above, these same phenomena are seenwhen catalase ismissing due
to protein or message instabilities, or when the enzyme is chemically
inactivated [15,16]. Importantly, restoration of peroxisomal catalase
through use of a genetically engineered variant of the enzyme, called
catalase-SKL, delays appearance of senescence markers in aging cells
[26]. Cellular reactive oxygen species are reduced and, interestingly,
mitochondrial integrity is restored. Speciﬁcally, catalase-SKL expression
reestablishesmitochondrialmembranepotential (normally dissipated as
cells age [29]) and reduces mitochondrial reactive oxygen species
production (normally elevated in senescing cells [26,29]).
The latter results suggest that a redox-sensitive peroxisome–
mitochondria interplay is at work in cells. Importantly, this extends
evidence of organelle cross-talk and functional cooperation previous-
ly summarized by Dr. Michael Schrader and colleagues [30,31]. With
the suggestion of such a relationship in mind, it is probably not
surprising then, that inactivating catalase with 3-amino-1,2,4-triazole
drives mitochondria to a depolarized [16], reactive oxygen species-
producing, state [16,32]. Peroxisomal catalase is cytoprotective; its
absence, mislocalization, or inactivation is progeric on cells, which begs
the question; can the antioxidant enzyme be introduced to cells— and if
so, would we not expect a signiﬁcant effect on age-, or oxidative stress-
induced cellular pathologies?2 Peroxisome proliferation may also reﬂect impaired turnover of the organelle.
Chaperone-mediated autophagy is compromised with age [27]; whether or not
autophagic processes directly responsible for peroxisome turnover are similarly
affected is not clear. However, see relevant references included in [3] and [28]
regarding links between cell senescence/aging and impaired autophagic pathways.3.4. Cell penetrating catalase-SKL
Catalase-SKL contains a reengineered peroxisome targeting signal at
its carboxy terminus. This enzyme interacts more avidly with the import
receptor, Pex5p [26], and is more efﬁciently imported into peroxisomes
[26]. The molecule was developed into a protein therapeutic by adding
a cell penetrating peptide near the amino terminus, along with a
polyhistidine tag — used for purifying the recombinant enzyme (see
Fig. 1 schematic). The following is a brief summary of the demonstrated
efﬁcacy of the cell penetrating antioxidant enzyme (hereafter referred to
as CAT-SKL) in a number of cell biological, physiological, and patho-
physiological contexts.
In a human cell model for psoriasis, CAT-SKL reduces tumor
necrosis factor-α-induced reactive oxygen species and downstream
inﬂammatory cytokine production [33]. In primary explants of
human skin, a topically applied hydrogel preparation of CAT-SKL
reduced ultraviolet light-induced lipid peroxidation by more than
60% as compared to a formulation base alone [34]. The molecule,
when formulated with appropriate excipients including skin pene-
trating agents, enters (mouse) skin and reduces hydrogen peroxide
levels [34]. Importantly, repeat insult patch test results indicate that
the CAT-SKL hydrogel elicited no “contact sensitization” reactions of
any kind when applied over 10 weeks to human subjects [34].
The results in skin may be relevant to radiation dermatitis — a side
effect of certain cancer treatments. Collaborative studies conducted at
our own institution [35] showed that CAT-SKL inhibited photodynamic
therapy-induced apoptosis in murine leukemia cells. In contrast, the
catalase inhibitor, 3-amino-1,2,4-triazole, potentiated the response.
These studies are important in that they demonstrate a role for
hydrogen peroxide in photodynamic therapy's pro-apoptotic effects,
and suggest that CAT-SKL might be beneﬁcial, that is, protective, if
applied to tissue adjacent to that undergoing a photodynamic therapy-
based treatment regimen. Also, the idea that inhibition of antioxidant
activity enhances photo- or radiation-killing may have important
implications for tumor elimination strategies.
Reactive oxygen species and resultant oxidative stress are thought
tobe themaindrivers of ischemia–reperfusion andhypoxia–reoxygenation
injuries in the heart. Our work with a neonatal ventricular myocyte
model showed CAT-SKL protected cells against these injurious events
[36]. Coupled with our unpublished evidence that the targeted
antioxidant reduces the area of necrosis, as a function of the area at
risk, in rats exposed to a 30 min ischemic event— the suggestion is that
CAT-SKL may represent a potentially powerful new therapeutic
modality for the protection of heart tissue from oxidative damage.
In two other as yet to be published lines of research, CAT-SKL
reduced the toxic effects of soluble β-amyloid peptides on cultured
embryonic rat hippocampal/cortical neurons [34], and sensitized
otherwise resistant breast cancer cells to the tyrosine kinase inhibitor,
geﬁtinib [37]. With respect to the former, these studies corroborate
work from Dr. Nibaldo Inestrosa and colleagues [38] showing a
protective role for peroxisomes and peroxisomal catalase in β-amyloid
induced neurodegeneration.
Non-SKL derivatized cell penetrating catalase molecules have also
been employed in a number of systems including those designed toFig. 1. CAT-SKL construct. See text for additional description.
AB
Fig. 2. Schematic representation of cellular senescence and its impact on organelles,
reactive oxygen species production, and cell architecture. A. As described in the text,
early passage/young cells contain peroxisomes and mitochondria that are fully capable
of processing reactive oxygen species produced in situ. B. Late passage/old cells are less
able to carry out these processes and amass the reactive metabolites. As a consequence
they manifest changes to organelles and the cell itself as illustrated.
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injuries in the heart [40], and to identify hydrogen peroxide-
dependent signaling pathways [41]. Regarding this last point; our
unpublished work looking at gene arrays and the effects of CAT-SKL
suggest elimination of CAT-SKL-sensitive reactive oxygen species may
reintroduce cell cycle checkpoint control in senescing cells. The fact
that catalase-SKL delays appearance of senescence markers [26],
whereas mislocalized catalase is associated with the senescent state
[25], is certainly consistent with these preliminary results.
One large emission from these completed or ongoing studies is a
longitudinal analysis, in animals, of the effects of supplementing
peroxisomal catalase. This could be accomplished, for example, in a
transgenic background with catalase-SKL as the introduced exoge-
nous gene. Catalase-SKL would be the preferred transgene to assure
more robust peroxisome trafﬁcking with age [25,26]. An alternative
approach could involve regular (intraperitoneal or subcutaneous)
administration of the recombinant protein, CAT-SKL. There are
advantages and disadvantages of both approaches including the
considerable time and expense of the requisite protocols. However,
generation of these animals would permit not only a longevity study,
but also an evaluation of their disease resistance after appropriate
crosses or physiological perturbations. One could reasonably expect
such animals to delay onset of age-related degenerative disease and
perhaps even live longer than control animals. Of course, this is
simply conjecture at this point.
Some ﬁnal thoughts on catalase. One recurring question is why
does catalase possess aweak perosixome targeting signal— a property
of the enzyme seen across evolutionary diverse organisms. Is it that
a kinetically delayed import process permits proper folding and
assembly of constituent protein and heme subunits? Is it, as
speculated previously [42], that import of the enzyme is sufﬁcient-
ly robust in young cells/organisms and that the compromised
compartmentalization seen in aging occurs after reproductive age
and cannot be selected against evolutionarily? Is it that advantages
exist for catalase to be partially localized to the cytosol?With respect to
the latter, consider that during red blood cell development, precursor
cells eliminate intracellular organelles [43]. Perhaps a partial cytosolic
localization preserves antioxidant capacities in the mature red blood
cell.
Lastly, overexpression of catalase in and of itself is not a panacea.
Several studies over the years have shown that enhanced levels of
antioxidant enzymes or mimetics may actually sensitize cells to toxic
insult — not insulate them. As pointed out recently by Dr. Epstein and
colleagues [44], catalase overexpression in β-cells of the mouse
pancreas actually sensitizes the animal to diabetes. Their explanation,
and one supported by an emerging consensus, is that indiscriminate
metabolism of reactive oxygen species in cells may very well be
detrimental. Reactive oxygen species in small amounts (~bursts) and in
particular locations, represent critical components of signaling cascades
and related communication networks. They cannot be indiscriminately
metabolized by broad-acting, non-targeted antioxidant strategies.
4. Conclusions and perspectives
Fig. 2 depicts a schematized version of two cells; a young cell at early
passage, and an old cell at, or near, replicative senescence. The albeit
simpliﬁed rendering reveals several important points. First, reactive
oxygen species can emanate fromperoxisomes andmitochondria— even
in young cells. The idea has emerged that these organellesmight release a
small but continuous stream of the reactive molecules to maintain
readiness of the antioxidant response aswell as to appropriately regulate
cell signaling, cell communication, and network integrating activities.
The sum total of these “hormetic” or “preconditioning” pathways may
very well be the anti-aging programs reviewed in [14]. However, the
perspective of this article has been onwhat happenswhen these reactive
oxygen species are produced beyond a speciﬁc threshold — when theybegin to amass and damage cell constituents and to initiate more pro-
aging programs. As we depict in the ﬁgure, peroxisomes and mitochon-
dria release reactive oxygen species—with each organelle affected by the
process. Peroxisomes proliferate with age [25,32], as do mitochondria
[45]. Peroxisomes are impaired in their ability to import their constituent
enzymes, [25,32], and begin to manifest functional deﬁcits. Mitochon-
drial functionality is also reduced— for example, their ability tomaintain
a membrane potential is impaired [26,29]. It should be noted that
mitochondrial DNA is exquisitely sensitive to oxidative stress and an
accumulation of mutations is seen as amajor driver of mammalian aging
[46].
It is nearly impossible to tease out where reactive oxygen species
begin and end in the cell. Is hydrogen peroxide produced ﬁrst in the
peroxisome and then “efﬁciently” diffuse to mitochondria where it
attacks perhaps more delicate components of the electron transport
chain? Or does trafﬁcking of the reactive metabolite and its down-
streamderivatives originate inmitochondria— the cell's “ﬁery furnace”?
Continuing with unanswered questions, only little has been included
here about the precise targets of organellar, or otherwise produced,
reactive oxygen species. What signaling pathways, communication
networks, and pro- or anti-aging programs are actually modulated by
these reactive molecules? It has been questioned whether aging
represents a sort of end point with respect to oxidative damage to
cellular constituents — or is it the culmination of an as yet undeﬁned,
development program? What is clear is that cellular reactive
oxygen species — and hydrogen peroxide in particular, is as suggested
by Drs. Teng Lu and Toren Finkel, a “primary mediator” of in vitro
senescence and in vivo aging [47]. Echoing the importance of hydrogen
peroxide, Drs. Michael Lisanti, Federica Sotgia and co-authors suggest
the molecule, via its ability to “drive accelerated aging”, constitutes a
major player in the etiology of inﬂammation and cancer [48].
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oxidative stress, aging, and the development of degenerative disease
is a role for peroxisomes. Although the extent of this role is yet to be
completely deﬁned — it is quite clear that peroxisomes will continue
to emerge as critical contributors to these processes.Conﬂict of interest
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